Why can't I stop my benzodiazepine on my own?

The FDA's boxed warning explains why: physical dependence can develop within days to weeks of steady use, even at prescribed doses, and stopping abruptly or cutting the dose too fast can cause withdrawal seizures and other life-threatening reactions, along with anxiety, insomnia, and sensory problems that can persist for months. The agency recommends a gradual taper planned and monitored with a health care professional.

What does Philadelphia's overdose data say about benzodiazepines?

Philadelphia recorded 1,069 unintentional overdose deaths in 2024, down 18% from 2023. The supply is heavily adulterated: xylazine appeared in 34% of all 2024 overdose deaths, and the sedative medetomidine appeared in 9% after entering the dope supply in May 2024. Research on Philadelphia Medical Examiner data found benzodiazepines present in 28.4% of xylazine-involved overdose deaths. Sedatives stack in this supply, and benzos are part of the mix.

Where do I go for a benzo taper or detox in Philadelphia?

Start with the prescriber who writes the benzo, an outpatient clinic, or — if you are uninsured, on Medicaid, or unsure of coverage — Community Behavioral Health (CBH) Member Services at 888-545-2600, answered 24/7, which connects Philadelphians to publicly funded substance use treatment including medically monitored detox. For emergency mental health or addiction crisis response, the Mental Health Delegates Line is 215-685-6440.

Is withdrawal worse if I also use opioids or drink?

Yes — benzodiazepines, opioids, and alcohol all depress breathing, so combining them compounds the risk, and the FDA boxed-warns benzos about use with opioids. Philadelphia's supply already contains sedatives like xylazine and medetomidine. A taper built by a clinician who knows everything you use is the plan that holds; a secret in the medical history is the thing that breaks it.

Benzodiazepine Detox and Tapering in Philadelphia, PA

Benzodiazepine withdrawal is the quiet danger in the medicine cabinet: the FDA has warned since 2020 that dependence forms quickly and that a sudden stop can cause seizures. Philadelphia adds its own layer of risk — the city's drug supply is now threaded with veterinary sedatives that stack on top of whatever a benzo is already doing. The city's overdose deaths are finally falling, but the supply is not getting safer. Here is how a supervised taper starts, and who to call tonight.

The medical case for a taper

Alprazolam, clonazepam, lorazepam, and the rest of the class calm the nervous system, which responds by recalibrating around them within days to weeks — even at prescribed doses. The FDA's updated boxed warning describes the consequence of an abrupt stop: withdrawal reactions including seizures, which can be life-threatening, plus rebound anxiety, insomnia, and sensory hypersensitivity that some patients report lasting months. The agency's instruction to prescribers is a gradual, individualized taper — no standard schedule fits everyone — with the plan slowed or paused when symptoms spike, then resumed.

What makes Philadelphia different is what else is on board. Philadelphia's Medical Examiner found xylazine in 34% of all 2024 overdose deaths and the newer sedative medetomidine in 9%, and published research on Medical Examiner data found benzodiazepines present in 28.4% of xylazine-involved overdose deaths. Sedatives accumulate. A taper clinician who knows the full picture can plan around it; one who doesn't, can't.

Philadelphia's data, briefly

The Philadelphia Department of Public Health's CHART report on 2024 deaths:

1,069 unintentional overdose deaths in 2024 — down 18% from 2023 and 24% below the record 1,413 in 2022.
Opioids were detected in 77% of deaths (822), with fentanyl in 93% of those; opioids and stimulants were co-detected in half of all deaths.
Xylazine: 34% (364 deaths). Medetomidine: 9% (92 deaths), after entering the supply in May 2024.
Emergency room presentations for drug withdrawal rose 89% from May to December 2024 after medetomidine entered the dope supply — a signal of how much sedative-related withdrawal is moving through local ERs.
Overdoses touched nearly every ZIP code, with the highest counts in Kensington-area 19134 (179 deaths), 19124, 19133, 19132, and 19140.

For a city of about 1.57 million people, the falling count is real progress, and the adulterated supply is real risk.

Where care starts in Philadelphia

CBH Member Services, 888-545-2600, 24/7/365 — Community Behavioral Health is the City of Philadelphia's behavioral health insurer for everyone enrolled in Medicaid, and its member line connects uninsured, Medicaid-covered, and unsure-of-coverage Philadelphians to publicly funded substance use treatment, including medically monitored detox and residential care. This is the single most direct door in the city.
Mental Health Delegates Line, 215-685-6440, 24/7 — the city's behavioral health emergency system, which dispatches mobile teams and access to Crisis Response Centers when a crisis needs more than a phone call.
Your prescriber or a buprenorphine-prescribing clinic — for a prescription-level benzo taper, the fastest route is often the clinician who already writes the medication, plus a full medication and use review.
The SAMHSA treatment locator — filter Philadelphia County facilities by detoxification and inpatient/residential levels of care.
Pennsylvania's statewide resources — the PA Department of Health and the Department of Drug and Alcohol Programs (DDAP) fund and license treatment statewide; DDAP's get-help resources extend beyond Medicaid to state-funded programs.

Paying for care

Pennsylvania Medical Assistance (Medicaid) covers substance use treatment, and in Philadelphia the benefit is administered through Community Behavioral Health for Medicaid members — the same 888-545-2600 line handles eligibility questions, service access, and prior authorization concerns. Services are available regardless of ability to pay; if you are uninsured, CBH can route you to publicly funded options.

How to start today

If someone is seizing, unresponsive, or struggling to breathe, call 911 immediately. A benzodiazepine withdrawal seizure — or a sedative-stacked overdose — belongs in an emergency department.
Call or text (800) 653-9376 to talk through detox and tapering options with a person, or use this form:

Calling is free; the referral service is paid for by treatment providers, and we check your benefits before you commit.

For a crisis that is not a medical emergency, call or text 988, or the Mental Health Delegates Line at 215-685-6440, any hour.
Tell the first clinician everything — prescriptions, alcohol, opioids, anything from the street. In a supply this adulterated, honesty is a safety feature.

This page is general health information, not medical advice. It is not affiliated with or endorsed by any facility named above.